CD8A and hepatocellular carcinoma: Regarding immune infiltration, the GLYlow/TMEhigh subgroup had elevated recruiting values for CD8 T, NK, T, and Th1 cells, indicating that this group of patients had good antitumor immunity, which was consistent with the expected effect, suggesting the feasibility of the model to anticipate the prognosis of HCC patients.